We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current DYN market cap is 2.15B. The company's latest EPS is USD -2.8788 and P/E is -9.12.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -42.28M | -40.15M | -45.46M | -66.74M | -62.27M |
| Net Income | -41.39M | -38.83M | -44.19M | -64.9M | -60.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.83M | -58.65M | -150.03M | -170.96M | -242.16M |
| Net Income | -14.86M | -59.44M | -149.29M | -168.1M | -235.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 299.68M | 306.33M | 288.64M | 251.42M | 205.24M |
| Total Liabilities | 49.94M | 53.96M | 46.71M | 44.54M | 53.21M |
| Total Equity | 249.74M | 252.36M | 241.94M | 206.88M | 152.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.44M | 353.33M | 425.66M | 306.33M | 165.08M |
| Total Liabilities | 2.4M | 10.97M | 57.47M | 53.96M | 73.79M |
| Total Equity | 14.04M | 342.37M | 368.2M | 252.36M | 91.29M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -124.45M | -153.65M | -46.91M | -102.55M | -153.15M |
| Investing | 67.97M | 87.2M | 27.06M | 44.29M | 57.12M |
| Financing | 187k | 37.39M | 28.82M | 53.72M | 54.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.83M | -46.51M | -119.56M | -153.65M | -188.16M |
| Investing | -1.65M | -45.66M | -137.89M | 87.2M | 83.31M |
| Financing | 19.99M | 380.69M | 157.82M | 37.39M | 54.32M |
| Market Cap | 2.15B |
| Price to Earnings Ratio | -9.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 17.69 |
| Price to Book Ratio | 23.57 |
| Dividend Yield | - |
| Shares Outstanding | 81.96M |
| Average Volume (1 week) | 856.51k |
| Average Volume (1 Month) | 797.31k |
| 52 Week Change | 88.17% |
| 52 Week High | 30.2687 |
| 52 Week Low | 6.40 |
| Spread (Intraday) | 20.85 (65.16%) |
| Company Name | Dyne Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.dyne-tx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
